Skip to main content
Novacyt logo

Novacyt — Investor Relations & Filings

Ticker · ALNOV ISIN · FR0010397232 LEI · 213800BWAC2BF295EG28 PA Manufacturing
Open in API
Filings indexed 1,101 across all filing types
Latest filing 2026-03-30 Director's Dealing
Country FR France
Listing PA ALNOV

About Novacyt

https://novacyt.com/

Novacyt is an international molecular diagnostics company that provides a broad portfolio of integrated technologies and services. The company's core activities include the design, development, manufacturing, and commercialization of in vitro and molecular diagnostic tests, with a specialization in real-time PCR (qPCR) kits and reagents. Novacyt's solutions are applied across various markets, including clinical diagnostics for human health, with a focus on infectious diseases and oncology, as well as animal health and food safety. The company also offers custom development services, contract manufacturing, and pharmaceutical research services such as whole genome sequencing.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 95% confidence The document is a market disclosure under EU MAR/UK MAR of share purchases by company directors (PDMRs). It provides details of the directors, nature of transaction (acquisition of ordinary shares), date, price, aggregated volume, LEI, and venue. This is a report of personal share transactions by directors, matching the Director’s Dealing category.
2026-03-30 English
Result of Preferential Subscription Rights Issue
Capital/Financing Update Classification · 100% confidence The document is an official announcement regarding the results of a 'Preferential Subscription Rights' (PSR) issue, which is a form of capital raising. It details the number of shares issued, the amount raised, the allocation of shares, and the impact on share capital. This falls under the category of capital/financing updates, as it describes the outcome of a specific financing activity rather than a general regulatory filing or a report publication announcement.
2026-03-20 English
Résultat de l’augmentation de capital avec maintien du droit préférentiel de souscription actionnaires
Share Issue/Capital Change Classification · 89% confidence The document is a press release reporting the results of a capital increase (rights issue) detailing the number of new shares issued, amounts raised, allocation of unsubscribed shares, change in share capital and voting rights. It clearly announces a new share issue (augmentation de capital), matching the Share Issue/Capital Change category.
2026-03-20 French
Liquidity Agreement Monthly Update and TVR
Transaction in Own Shares Classification · 95% confidence The document is a monthly update regarding a liquidity agreement and total voting rights for Novacyt S.A. It details share purchases and sales made by a third party (Invest Securities) under a liquidity agreement, as well as the total number of shares and voting rights. This type of disclosure, specifically regarding share buybacks/transactions in own shares and voting rights updates, falls under the 'Transaction in Own Shares' category.
2026-03-02 English
Information mensuelle sur le contrat de liquidité et sur le nombre total de droits de vote
Transaction in Own Shares Classification · 95% confidence The document is a monthly disclosure from Novacyt regarding its liquidity contract (share buybacks/sales) and the total number of voting rights. This type of regulatory disclosure, which reports on the company's own share transactions and capital structure, is standard for European-listed companies and falls under the category of 'Transaction in Own Shares' (POS) as it details the specific buy/sell activity of the liquidity provider and the resulting treasury share count.
2026-03-02 French
Preferential Subscription Rights Issue
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement by Novacyt S.A. regarding a 'Preferential Subscription Rights Issue' to raise capital. It details the subscription price, ratio, subscription period, and the legal framework for the capital increase. This falls squarely under the definition of a 'Share Issue/Capital Change' (SHA) announcement, as it describes the issuance of new shares and the mechanics of the rights offering.
2026-03-02 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.